Narjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma

肺大细胞神经内分泌癌的整合分子与临床特征分析

Nature Communications

IF15.7

2025-08-190

Amin H. Nassar; Chul Kim; Tolulope Adeyelu; Elias Bou Farhat; Hassan Abushukair; Mehrdad Rakaee; Kelsey Matteson; Shun-Fat Lau; Yamato Takabe; Antonio Ocejo; Fatemeh Ardeshir-Larijani; Ticiana Leal; Suresh Ramalingam; Sumaiya Alam; Jhanelle E. Gray; James Hicks; David Kaldas; Javier Baena; Maria Zurera Berjaga; Frank Aboubakar Nana; Christian Grohe; Heike Leuders; Fabrizio Citarella; Alessio Cortellini; Emanuele Claudio Mingo; Danny Pancirer; Millie Das; Timothy John Ellis-Caleo; Justin M. Cheung; Jessica J. Lin; Alexander S. Watson; D. Ross Camidge; Arthi Sridhar; Kaushal Parikh; Fionnuala Crowley; Thomas U. Marron; Vanya Aggarwal; Murtaza Ahmed; Kamya Sankar; Hassan Kawtharany; Jun Zhang; Dwight H. Owen; Mingjia Li; Misako Nagasaka; David J. Pinato; Nichola Awosika; Khaled Alhamad; Sonam Puri; Unaiza Zaman; Divya M. Gupta; Chelsea Lau; Hina Khan; Justin Liauw; Ana I. Velazquez; Tyiesha Brown; Laura Moliner; Miguel Mosteiro; Pedro Rocha; Mark Evans; Ari Vanderwalde; Andrew Elliott; Jorge Nieva; Gilberto Lopes; Patrick C. Ma; Hossein Borghaei; Matthew Lee; Lauren Young; Raid Aljumaily; Haris Mirza; David J. Kwiatkowski; Roy S. Herbst; Richard A. Flavell; Abdul Rafeh Naqash; Anne C. Chiang

Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials

数字与人工PD-L1评分在晚期非小细胞肺癌中的应用比较：基于IMpower110和IMpower150试验

Journal of Thoracic Oncology

IF20.8

2025-08-050

PRE

Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer: Phase 3 LEAP-006 Study

仑伐替尼联合帕博利珠单抗、培美曲塞和铂类药物作为转移性非鳞状非小细胞肺癌的一线治疗方案：III期LEAP-006研究

Journal of Thoracic Oncology

IF20.8

2025-05-240

PREAI

The evolving immuno-angiogenic paradigm in NSCLC: lessons from ivonescimab

NSCLC中不断发展的免疫血管生成范式: ivonescimab的经验教训

Nature Reviews Clinical Oncology

IF82.2

2025-05-060

PRE

Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer

奥希替尼辅助治疗切除的EGFR突变IB-IIIA期非小细胞肺癌的分子残留病灶分析

NATURE MEDICINE

IF50

2025-03-170

Optimizing public-private partnerships to support clinical cancer research

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2024-12-120

PRE

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

CTLA4阻断消除KEAP1/STK11-related对PD-(L)1抑制剂的抗性

Nature

IF48.5

2024-10-090

OAAI

Ferdinandos Skoulidis; Haniel A. Araujo; Minh Truong Do; Yu Qian; Xin Sun; Ana Galan-Cobo; John T. Le; Meagan Montesion; Rachael Palmer; Nadine Jahchan; Joseph M. Juan; Chengyin Min; Yi Yu; Xuewen Pan; Kathryn C. Arbour; Natalie Vokes; Stephanie T. Schmidt; David Molkentine; Dwight H. Owen; Regan Memmott; Pradnya D. Patil; Melina E. Marmarelis; Mark M. Awad; Joseph C. Murray; Jessica A. Hellyer; Justin F. Gainor; Anastasios Dimou; Christine M. Bestvina; Catherine A. Shu; Jonathan W. Riess; Collin M. Blakely; Chad V. Pecot; Laura Mezquita; Fabrizio Tabbó; Matthias Scheffler; Subba Digumarthy; Meghan J. Mooradian; Adrian G. Sacher; Sally C. M. Lau; Andreas N. Saltos; Julia Rotow; Rocio Perez Johnson; Corinne Liu; Tyler Stewart; Sarah B. Goldberg; Jonathan Killam; Zenta Walther; Kurt Schalper; Kurtis D. Davies; Mark G. Woodcock; Valsamo Anagnostou; Kristen A. Marrone; Patrick M. Forde; Biagio Ricciuti; Deepti Venkatraman; Eliezer M. Van Allen; Amy L. Cummings; Jonathan W. Goldman; Hiram Shaish; Melanie Kier; Sharyn Katz; Charu Aggarwal; Ying Ni; Joseph T. Azok; Jeremy Segal; Lauren Ritterhouse; Joel W. Neal; Ludovic Lacroix; Yasir Y. Elamin; Marcelo V. Negrao; Xiuning Le; Vincent K. Lam; Whitney E. Lewis; Haley N. Kemp; Brett Carter; Jack A. Roth; Stephen Swisher; Richard Lee; Teng Zhou; Alissa Poteete; Yifan Kong; Tomohiro Takehara; Alvaro Guimaraes Paula; Edwin R. Parra Cuentas; Carmen Behrens; Ignacio I. Wistuba; Jianjun Zhang; George R. Blumenschein; Carl Gay; Lauren A. Byers; Don L. Gibbons; Anne Tsao; J. Jack Lee; Trever G. Bivona; D. Ross Camidge; Jhannelle E. Gray; Natasha B. Leighl; Benjamin Levy; Julie R. Brahmer; Marina C. Garassino; David R. Gandara; Edward B. Garon; Naiyer A. Rizvi; Giorgio Vittorio Scagliotti; Jürgen Wolf; David Planchard; Benjamin Besse; Roy S. Herbst; Heather A. Wakelee; Nathan A. Pennell; Alice T. Shaw; Pasi A. Jänne; David P. Carbone; Matthew D. Hellmann; Charles M. Rudin; Lee Albacker; Helen Mann; Zhou Zhu; Zhongwu Lai; Ross Stewart; Solange Peters; Melissa L. Johnson; Kwok K. Wong; Alan Huang; Monte M. Winslow; Michael J. Rosen; Ian P. Winters; Vassiliki A. Papadimitrakopoulou; Tina Cascone; Philip Jewsbury; John V. Heymach

Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer With a High-Sensitivity Assay

MODERN PATHOLOGY

IF5.5

2024-09-010

PRE

A genomic scar based signature (HRDsig) and biallelic BRCA alterations identify a homologous recombination deficiency (HRD) phenotype of non-small cell lung cancer (NSCLC) potentially actionable to the PARP inhibitor rucaparib: Post-hoc analysis of lung-MAP substudy S1900A

基于基因组疤痕特征的签名（HRDsig）和双等位基因BRCA突变可识别非小细胞肺癌（NSCLC）的同源重组缺陷（HRD）表型，该表型可能对PARP抑制剂rucaparib具有潜在可操作性：肺-MAP亚研究S1900A的事后分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC